Form 8-K - Current report:
SEC Accession No. 0001437749-25-018336
Filing Date
2025-05-23
Accepted
2025-05-23 16:04:27
Documents
15
Period of Report
2025-05-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K clnn20250521_8k.htm   iXBRL 8-K 43179
2 EXHIBIT 10.1 ex_822157.htm EX-10.1 67526
3 EXHIBIT 10.2 ex_822158.htm EX-10.2 19577
  Complete submission text file 0001437749-25-018336.txt   303167

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA clnn-20250521.xsd EX-101.SCH 4123
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clnn-20250521_def.xml EX-101.DEF 13919
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE clnn-20250521_lab.xml EX-101.LAB 18404
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clnn-20250521_pre.xml EX-101.PRE 13951
17 EXTRACTED XBRL INSTANCE DOCUMENT clnn20250521_8k_htm.xml XML 5097
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

EIN.: 852828339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39834 | Film No.: 25982072
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)